These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
41 related articles for article (PubMed ID: 19586760)
21. Rhesus haemolytic disease of the newborn: Postnatal management, associated morbidity and long-term outcome. Smits-Wintjens VE; Walther FJ; Lopriore E Semin Fetal Neonatal Med; 2008 Aug; 13(4):265-71. PubMed ID: 18387863 [TBL] [Abstract][Full Text] [Related]
22. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis]. Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032 [TBL] [Abstract][Full Text] [Related]
23. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn]. Miquel E; Cavelier B; Bonneau JC; Rouger P Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293 [TBL] [Abstract][Full Text] [Related]
24. [Biochemical and hematometric effects of exchange transfusion in isoimmunized neonates]. Jurfest-Ceccon ME; de Albuquerque Diniz EM; de Araujo-Ramos JL; Costa-Vaz FA Bol Med Hosp Infant Mex; 1993 Mar; 50(3):167-76. PubMed ID: 8442881 [TBL] [Abstract][Full Text] [Related]
25. Should intravenous immunoglobulin be used in infants with isoimmune haemolytic disease due to ABO incompatibility? Keir AK; Dunn M; Callum J J Paediatr Child Health; 2013 Dec; 49(12):1072-8. PubMed ID: 24325716 [TBL] [Abstract][Full Text] [Related]
26. Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization. Rath ME; Smits-Wintjens VE; Walther FJ; Lopriore E Early Hum Dev; 2011 Sep; 87(9):583-8. PubMed ID: 21798676 [TBL] [Abstract][Full Text] [Related]
27. Fetal and neonatal cytopenias: what have we learned? Bussel JB Am J Perinatol; 2003 Nov; 20(8):425-31. PubMed ID: 14703590 [TBL] [Abstract][Full Text] [Related]
32. A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin. Spurlock NK; Prittie JE J Vet Emerg Crit Care (San Antonio); 2011 Oct; 21(5):471-83. PubMed ID: 22316195 [TBL] [Abstract][Full Text] [Related]
33. Prenatal high-dose immunoglobulin treatment for neonatal hemochromatosis: a case report and review of the literature. Tanaka H; Haba R; Itoh S; Sakamoto H; Hata T J Obstet Gynaecol Res; 2011 Dec; 37(12):1891-4. PubMed ID: 22070213 [TBL] [Abstract][Full Text] [Related]
34. [High-dose intravenous immunoglobulin therapy and neonatal jaundice due to red blood cell alloimmunization]. Monpoux F; Dageville C; Maillotte AM; De Smet S; Casagrande F; Boutté P Arch Pediatr; 2009 Sep; 16(9):1289-94. PubMed ID: 19586760 [TBL] [Abstract][Full Text] [Related]
35. Intravenous immunoglobulin in the management of hemolytic disease of the newborn. Mundy CA Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181 [TBL] [Abstract][Full Text] [Related]
36. Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis. Louis D; More K; Oberoi S; Shah PS Arch Dis Child Fetal Neonatal Ed; 2014 Jul; 99(4):F325-31. PubMed ID: 24514437 [TBL] [Abstract][Full Text] [Related]
37. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Newman TB; Maisels MJ Pediatrics; 1992 May; 89(5 Pt 1):809-18. PubMed ID: 1579380 [TBL] [Abstract][Full Text] [Related]